Sales: $403 million.
Key Personnel: Jeff Olson, chief executive officer; Jeffrey Dahl, co-chief executive officer; Renee Olson, chief leadership officer; Dennis Windsor, chief networking officer; Roy Truett, president of international; Amber Olson Rourke, chief marketing officer; Pilar Duque, vice president, scientific and regulatory affairs.
Major Products: Anti-aging skin care products.
New Products: Age-Defying Night Cream, NeriumAD Formula Age-Defying Day Cream, NeriumAD Formula Firming Body Contour Cream, NeriumAD Formula, Age-Defying Night Cream, Optimera Formula, Age-Defying Day Cream, Optimera Formula. To be launched: EHT Age-Defying Supplement, Mind Enhancement Formula (Fall 2015).
Comments: Nerium’s annual revenues came in at $403 million in 2014, up 119% over the year before. That leap landed the firm on Direct Selling News’ $100 million growth club list, and helped fuel its growing philanthropic endeavors. Since 2012, Nerium has contributed more than $2 million to Big Brothers Big Sisters.
At its annual national conference in Philadelphia in June, Big Brothers Big Sisters of America named Nerium as its 2015 President’s Award recipient—its highest corporate honor.
This year, Nerium launched a new charitable organization called the Nerium Ripple Foundation, which encourages the firm’s “independent brand partners” to live the company’s core value of “servant leadership” and the vision of “Making People Better” by making positive efforts —or ripples—throughout the world. The Nerium Ripple Foundation will work exclusively with nonprofit partners selected for each country where Nerium International does business.
Last month, Nerium’s Optimera Formula line of products became available for sale in South Korea through independent brand partners and online. The company entered the Canadian and Mexican markets during 2014.
The Optimera Formula features SIG-1273, billed as a new, breakthrough anti-aging ingredient created by Princeton University biochemist Dr. Jeffry B. Stock after 20 years of biomedical research. SIG-1273 is a dual-action, patented molecule specifically designed to provide superior anti-aging benefits as it addresses the signs of aging and its causes and acts as a powerful antioxidant to target free-radical damage while mimicking the skin’s natural age-fighting mechanism.